Sign in
2-Year Outcomes From Randomized Trials of Anti-VEGF Treatments for Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)
Geeta A. Lalwani, MD
Annual Meeting Talks
2018
The Changing Avastin Landscape
Paul Hahn, MD, PhD, FASRS
2019
Primary Results for Protocol AB
Andrew N. Antoszyk, MD FASRS
Updates from the Field
2020
Category: Pharmacology